# Hubei Haosun Pharmaceutical Co., Ltd., Ezhou, China – FDA Inspections

Source: https://www.keypedia.com/companies/hubei-haosun-pharmaceutical-co-ltd/a8ee3f4d-8f6b-432f-8452-d04dc31a1eee

> Inspection records and compliance data for Hubei Haosun Pharmaceutical Co., Ltd. in Ezhou. 5 FDA inspections on record, last inspected August 01, 2025.

---

## Details

- Name: Hubei Haosun Pharmaceutical Co., Ltd.
- FEI Number: 3005178749
- Business Operations: API MANUFACTURE, API/FDF ANALYTICAL TESTING, PACK, REPACK
- Address Line 1: Gedian Economic & Technology Dev. Area, No. 20 Juxian Road
- City: Ezhou
- Country Name: China
- Address: Gedian Economic & Technology Dev. Area, No. 20 Juxian Road, Ezhou, China
- Country: China

## Related Documents

- [FDA Inspection 1280335 - Hubei Haosun Pharmaceutical Co., Ltd. - 2025-08-01](https://www.keypedia.com/records/fda_inspections/hubei-haosun-pharmaceutical-co-ltd/6156ac7f-e283-400a-a016-0393c05bf7c5) — source: FDA, date: August 1, 2025
- FDA Inspection 1280335 - Hubei Haosun Pharmaceutical Co., Ltd. - 2025-08-01 — classification: No Action Indicated (NAI), source: FDA, date: August 1, 2025
- FDA Inspection 1047621 - Hubei Haosun Pharmaceutical Co., Ltd. - 2018-03-09 — classification: No Action Indicated (NAI), source: FDA, date: March 9, 2018
- [FDA Inspection 988662 - Hubei Haosun Pharmaceutical Co., Ltd. - 2016-09-02](https://www.keypedia.com/records/fda_inspections/hubei-haosun-pharmaceutical-co-ltd/2ce1f1f8-37cd-4112-9b2b-ac1dfaca97f6) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 2, 2016
- [EMA GMP - Hubei Haosun Pharmaceutical Co., Ltd. - sukls206914/2015 - 2016-01-20](https://www.keypedia.com/records/ema/hubei-haosun-pharmaceutical-co-ltd/9d99abfa-6398-4212-9fda-bf485cc42d20) — source: EMA, date: January 20, 2016
- FDA Inspection 867397 - Hubei Haosun Pharmaceutical Co., Ltd. - 2013-11-15 — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 15, 2013
- FDA Inspection 738545 - Hubei Haosun Pharmaceutical Co., Ltd. - 2011-07-16 — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 16, 2011

## Related Companies

- [Dishman Carbogen Amcis Limited](https://www.keypedia.com/companies/dishman-carbogen-amcis-limited/d3284991-5957-400b-8562-f745b3c4bd73)
- [Changzhou Yinsheng Pharmaceutical Co. Ltd.](https://www.keypedia.com/companies/changzhou-yinsheng-pharmaceutical-co-ltd/1733699b-c043-4f11-9c7f-f897247a8ea8)
- [Jiangxi Synergy Pharmaceutical, Co., Ltd.](https://www.keypedia.com/companies/jiangxi-synergy-pharmaceutical-co-ltd/9602f29a-9a10-4201-966c-b89b6a2d3ae5)
- [Zhejiang Cheng Yi Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/zhejiang-cheng-yi-pharmaceutical-co-ltd/dabc68a0-9969-418a-9cd6-54e9987ed8df)
- [HEC Pharm Co., Ltd.](https://www.keypedia.com/companies/hec-pharm-co-ltd/23b5826b-1111-4f49-a0ff-3b8731995caf)
- [Wuhan Biocause Pharmaceutical Development Co., Ltd.](https://www.keypedia.com/companies/wuhan-biocause-pharmaceutical-development-co-ltd/79c352a3-22a2-471e-abbe-1802683656eb)
- [Zhejiang Kangle Pharmaceutical Co., Ltd (Binhai Plant)](https://www.keypedia.com/companies/zhejiang-kangle-pharmaceutical-co-ltd-binhai-plant/13be9174-238f-43cf-bdf4-0c57cc0b0bc2)
- [Anqiu Lu'an Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/anqiu-luan-pharmaceutical-co-ltd/18b1a266-0f5f-46cc-99de-8ee48dd42b49)
- [Alchem International Ltd.](https://www.keypedia.com/companies/alchem-international-ltd/e0374c19-b004-479a-b1c1-489fad51c063)
- [Arevipharma GmbH](https://www.keypedia.com/companies/arevipharma-gmbh/d2cf1bd6-f918-449d-83e7-70065b9cb728)